AB
ADCT icon

Amalgamated Bank’s ADC Therapeutics ADCT Stock Holding History

Amalgamated Bank’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,710
Closed -$10K – 1638
2025
Q4 		$10K Buy
2,710
+288
+12% +$1.17K ﹤0.01% 2403
2025
Q3 		$10K Hold
2,422
– – ﹤0.01% 2446
2025
Q2 		$6K Hold
2,422
– – ﹤0.01% 2625
2025
Q1 		$3K Hold
2,422
– – ﹤0.01% 2762
2024
Q4 		$5K Hold
2,422
– – ﹤0.01% 2698
2024
Q3 		$8K Hold
2,422
– – ﹤0.01% 2530
2024
Q2 		$8K Buy
+2,422
New +$9.63K ﹤0.01% 2537

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's ADCT Position: Q1 2026 in Review

Amalgamated Bank sold out of ADC Therapeutics (ADCT) in Q1 2026, closing a stake of 2,710 shares — an estimated $10K sold.

Amalgamated Bank first reported a position in ADCT in Q2 2024 and held it in 7 quarters. The position peaked at $10K in Q4 2025. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Amalgamated Bank reported no remaining ADC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,710 ADC Therapeutics shares in Q1 2026, an estimated $10K.
  • Amalgamated Bank first reported a position in ADC Therapeutics in Q2 2024 and held it in 7 quarters.
  • Amalgamated Bank's ADC Therapeutics position peaked at $10K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.